Cardiff Oncology Inc. sell DrMabuse
Start price
03.09.20
/
50%
€2.10
Target price
03.09.20
-
Performance (%)
-
End price
03.09.20
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -3.009% | -3.009% | 22.515% | -62.920% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% | 15.757% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% | 35.363% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% | 10.532% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% | 36.692% |
According to DrMabuse what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
High risks for its business
Comments by DrMabuse for this prediction
In the thread Trovagene diskutieren
Sell Cardiff Oncology Inc.
In the thread Trading Trovagene
Sell beendet
Stopped prediction by DrMabuse for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
19.09.20
19.09.20
-
29.09.20
29.09.20
72.97%
29.09.20
29.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€4.94
06.09.20
06.09.20
-
19.09.20
19.09.20
49.80%
19.09.20
19.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.65
22.08.20
22.08.20
-
03.09.20
03.09.20
-11.28%
03.09.20
03.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€5.40
08.08.20
08.08.20
-
21.08.20
21.08.20
23.15%
21.08.20
21.08.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.80
25.07.20
25.07.20
-
08.08.20
08.08.20
42.11%
08.08.20
08.08.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.06
14.06.20
14.06.20
-
27.06.20
27.06.20
111.65%
27.06.20
27.06.20
High risks for its business